Search for: "LaBelle v. LaBelle" Results 6881 - 6900 of 12,213
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2011, 2:30 am by Marie Louise
(FDA Law Blog) (Out-Law) US: FDA maintains that preparation of an NDI notification takes 20 hours (FDA Law Blog) US: Public Citizen petitions FDA to amend generic drug labeling regulations in the wake of Mensing (FDA Law Blog)   Products Combigan (Brimonidine, Timolol) – US: Allergan secures infringement ruling against generics in Combigan patent suit (Patent Docs) Copaxone (Glatiramer acetate) – US: Teva suit against generic Momenta over Copaxone proceeds in SDNY (IPBiz)… [read post]
4 Oct 2010, 4:55 am by Omar Ha-Redeye
But the court also tied this fairness element to the libel tourism issue raised by Canton, [86]     I agree with the motion judge that it is not appropriate to label it forum shopping or libel tourism if the party has a real and substantial connection with the forum: see Amchem Products Inc. v. [read post]
25 Nov 2013, 4:36 am
Dossantos, initiated sexually explicit conversations in an internet chat room, optimistically labeled `Connecticut Romance. [read post]
25 Jan 2021, 1:31 am by Rose Hughes
   The key prior art identified by Pharmascience was a small pilot open-label clinical trial demonstrating the efficacy of 20 mg glatiramer acetate every other day in MS patients (e.g. [read post]